Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic control analysis and mitochondrial pathologies

T Letellier1, M Malgat, R Rossignol

  • 1CJF-INSERM 97-05, Université Victor Ségalen Bordeaux 2, France.

Molecular and Cellular Biochemistry
|September 24, 1998
PubMed
Summary

Mitochondrial diseases show a high threshold for expression, with 10% normal DNA often sufficient. Metabolic compensation, reinforced by gene expression, explains this threshold, leading to a "double threshold hypothesis" for disease onset.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repression of oxidative phosphorylation by NR2F2, MTERF3 and GDF15 in human skin under high-glucose stress.

Redox biology·2025
Same author

Mitochondrial quinone redox states as a marker of mitochondrial metabolism.

Biochimica et biophysica acta. Bioenergetics·2024
Same author

The Warburg effect and mitochondrial oxidative phosphorylation: Friends or foes?

Biochimica et biophysica acta. Bioenergetics·2022
Same author

Applying FAIR Principles to Plant Phenotypic Data Management in GnpIS.

Plant phenomics (Washington, D.C.)·2020
Same author

Cell energy metabolism: An update.

Biochimica et biophysica acta. Bioenergetics·2020
Same author

Mitochondrial functions and rare diseases.

Molecular aspects of medicine·2020

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genetics

Background:

  • Mitochondrial diseases are characterized by a threshold effect where a significant deficit in mitochondrial function is required for disease manifestation.
  • This threshold is often high, with up to 90% mutated DNA (heteroplasmy) tolerated before symptoms appear, indicating substantial compensatory mechanisms.
  • Normal DNA levels as low as 10% can maintain near-normal mitochondrial oxidative phosphorylation flux.

Purpose of the Study:

  • To investigate the mechanisms underlying the threshold phenomenon in mitochondrial diseases.
  • To explore the role of metabolic compensation and gene expression regulation in maintaining mitochondrial function.
  • To propose a "double threshold hypothesis" linking mitochondrial deficits to tissue energy demands for disease onset.

Main Methods:

Related Experiment Videos

  • Metabolic Control Analysis (MCA) was employed to analyze the control coefficients of deficient mitochondrial steps.
  • Mathematical modeling was used to simulate the effects of transcriptional and translational adjustments on the threshold.
  • The study correlated the degree of mitochondrial deficit with observed oxidative flux and considered tissue-specific energy demands.

Main Results:

  • Metabolic compensation significantly buffers mitochondrial deficits; for example, a 70% cytochrome oxidase deficit reduced oxidative flux by only 10%.
  • Similar compensatory patterns were observed across other mitochondrial complexes.
  • Metabolic Control Analysis confirmed that the threshold value is intrinsically linked to the control coefficient of the impaired mitochondrial step.
  • Mathematical models demonstrated that minor increases in transcriptional and translational levels reinforce the threshold.
  • A correlation was established between the deficit expression threshold and tissue energy demand thresholds.

Conclusions:

  • The high threshold for mitochondrial disease expression is primarily driven by metabolic compensation, with support from transcriptional and translational regulation.
  • The "double threshold hypothesis" provides a framework for understanding the varied clinical presentations of mitochondrial diseases based on the interplay between cellular deficits and tissue energy needs.
  • Understanding these thresholds is crucial for diagnosing and potentially treating mitochondrial disorders.